[HTML][HTML] A roadmap for increasing the usefulness and impact of patient-preference studies in decision making in health: a good practices report of an ISPOR task force
Many qualitative and quantitative methods are readily available to study patient preferences
in health. These methods are now being used to inform a wide variety of decisions, and …
in health. These methods are now being used to inform a wide variety of decisions, and …
Participatory Value Evaluation (PVE): A New Preference-Elicitation Method for Decision Making in Healthcare
Participatory value evaluation (PVE) has recently been introduced in the field of health as a
new method to elicit stated preferences for public policies. PVE is a method in which …
new method to elicit stated preferences for public policies. PVE is a method in which …
Patient preference studies for advanced prostate cancer treatment along the medical product life cycle: systematic literature review
D Menges, MC Piatti, T Cerny… - Patient preference and …, 2022 - Taylor & Francis
Background Patient preference studies can inform decision-making across all stages of the
medical product life cycle (MPLC). The treatment landscape for advanced prostate cancer …
medical product life cycle (MPLC). The treatment landscape for advanced prostate cancer …
[HTML][HTML] Discrete choice experiment versus swing-weighting: A head-to-head comparison of diabetic patient preferences for glucose-monitoring devices
C Whichello, I Smith, J Veldwijk, GA de Wit… - PLoS …, 2023 - journals.plos.org
Introduction Limited evidence exists for how patient preference elicitation methods compare
directly. This study compares a discrete choice experiment (DCE) and swing-weighting (SW) …
directly. This study compares a discrete choice experiment (DCE) and swing-weighting (SW) …
[HTML][HTML] How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI …
R Janssens, L Barbier, M Muller, I Cleemput… - Frontiers in …, 2023 - frontiersin.org
Objective: Patients have unique insights and are (in-) directly affected by each decision
taken throughout the life cycle of medicinal products. Patient preference studies (PPS) …
taken throughout the life cycle of medicinal products. Patient preference studies (PPS) …
[HTML][HTML] Quantitative benefit-risk assessment in medical product decision making: a good practices report of an ISPOR task force
T Tervonen, J Veldwijk, K Payne, X Ng, B Levitan… - Value in Health, 2023 - Elsevier
Benefit-risk assessment is commonly conducted by drug and medical device developers
and regulators, to evaluate and communicate issues around benefit-risk balance of medical …
and regulators, to evaluate and communicate issues around benefit-risk balance of medical …
[HTML][HTML] User experience research in the development of digital health products
M Blanchard - Health Policy and Technology, 2023 - Elsevier
Background Digital health solutions are facing an increasing impact on healthcare. The
current scientific focus is mainly set on clinical studies providing efficacy for different …
current scientific focus is mainly set on clinical studies providing efficacy for different …
[HTML][HTML] The impact of video-based educational materials with voiceovers on preferences for glucose monitoring technology in patients with diabetes: a randomised …
IP Smith, CL Whichello, EW de Bekker-Grob… - The Patient-Patient …, 2023 - Springer
Introduction Ensuring patients have enough information about healthcare choices prior to
completing a preference study is necessary to support the validity of the findings. Patients …
completing a preference study is necessary to support the validity of the findings. Patients …
[HTML][HTML] Multistakeholder perceptions of additional value elements for United States value assessment of health interventions
Objectives Limitations in conventional cost-effectiveness methods have led to calls for
incorporation of additional value elements in assessments of health technologies. However …
incorporation of additional value elements in assessments of health technologies. However …
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance
G Simons, EM Janssen, J Veldwijk… - RMD open, 2022 - rmdopen.bmj.com
Objectives To quantify tolerance to risks of preventive treatments among first-degree
relatives (FDRs) of patients with rheumatoid arthritis (RA). Methods Preventive treatments for …
relatives (FDRs) of patients with rheumatoid arthritis (RA). Methods Preventive treatments for …